Resources

Publications

In What Circumstances Could Non-daily Pre-exposure Prophylaxis for HIV Substantially Reduce Program Costs? A HPTN 067/ADAPT based study

Kate M. Mitchell, Dobromir Dimitrov, James P. Hughes, Fan Xia, Deborah Donnell, K. Rivet Amico, Kevin Bokoch, Anupong Chitwarakorn, Linda-Gail Bekker, Timothy H. Holtz, Sharon Mannheimer, Robert M. Grant, Marie-Claude Boily

AIDS, 32(6):809-818 (2018)

Understanding the HIV Epidemic Among MSM in Baltimore: A Modelling Study Estimating the Impact of Past HIV Interventions and Who Acquired and Contributed to Infections

Romain Silhol, Marie-Claude Boily, Dobromir Dimitrov, Danielle German, Colin Flynn, Jason E Farley, Marcy Gelman, James P Hughes, Deborah Donnell, Adeola Adeyeye, Robert H Remien, Chris Beyrer, Gabriela Paz-Bailey, Cyprian Wejnert, Kate M Mitchell

JAIDS

Assessing the utility of the tipping point ratio to monitor HIV treatment programme in the era of universal access to ART

Simon de Montigny, Marie-Claude Boily, Benoît Mâsse, Kate M Mitchell, Dobromir Dimitrov

Infectious Disease Modelling, 3: 85-96 (2018)

Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study

Kate M Mitchell, Holly J Prudden, Reynold Washington, Shajy Isac, Subramanian P Rajaram, Anna M Foss, Fern Terris-Prestholt, Marie-Claude Boily, Peter Vickerman

Journal of the International AIDS Society, 19:20942 (2016)

PrEP adherence patterns strongly impact individual HIV risk and observed efficacy in randomized clinical trials

Dobromir T. Dimitrov, Benoît R. Mâsse, Deborah Donnell

JAIDS 72(4):444-451 (2016)

A curative regimen would decrease HIV prevalence but not HIV incidence unless targeted to an ART-naïve population

Dobromir Dimitrov, Hans-Peter Kiem, Keith R. Jerome, Christine Johnston, Joshua T. Schiffer

Scientific Reports. 6:22183 (2016)

See all Publications

Presentations

R4P 2016 – HIV Research for Prevention (Chicago)

Potential Impact on HIV Incidence of Increasing Viral Suppression among HIV-positive MSM in Baltimore: Mathematical… read more
ICASA 2015 – 18th International Conference on AIDS and STIs in Africa (Zimbabwe)

Modeling HIV transmission and prevention in Côte d’Ivoire: impacts of a national accelerated response plan… read more
R4P 2014 – HIV Research for Prevention (Cape Town)

Analysis of Experts’ Opinion and Its Influence on the Projected Public Health Impact of Drug… read more
CAHR 2016 – 25th Annual Canadian Conference on HIV/AIDS Research (Winnipeg)

In What Circumstances Could Non-daily Pre-exposure Prophylaxis (PrEP) Substantially Reduce Program Costs (HPTN 067)? Kate… read more
R4P 2018 – HIV Research for Prevention (Madrid)

Potential Impact of increased ART and PrEP coverage on the HIV Epidemic among MSM in… read more
ISI 2017 – 61st ISI World Statistics Congress (Marrakech)

Analysis of the Impact of the heterogeneity in exposure to HIV on the results of… read more

See all Presentations

Meetings/workshops

HPTN annual meeting 2014 (Washington DC)

Plenary: Modelling the impact of different patterns of adherence to PrEP on the observed efficacy… read more
HPTN annual meeting 2017 (Washington DC)

Modelling plenary: Cost-effectiveness of financial incentives for viral suppression. An Economic Model of HPTN 065. Blythe… read more
Global HIV Vaccine Enterprise 2017

Impact and cost-effectiveness of HIV prevention: Data inputs for HIV models and how they inform HIV… read more
HPTN annual meeting 2016 (Washington DC)

HPTN Modelling Center Plenary Introducing HPTN Modelling Centre: Who? What? When? How? Marie-Claude Boily Loading... Taking too long?… read more
HPTN annual meeting 2015 (Washington DC)

Plenary: The promise of PrEP among key populations in concentrated HIV epidemics Kate M. Mitchell… read more
NIH RAPIDD Workshop (2015) on : integrating mathematical models with the design and analysis of clinical trials to assess the efficacy of disease prevention and control interventions (Seattle)

The Role of Mathematical Modelling to Design, Conduct, Interpret and Replicate HIV Prevention Trials Dobromir… read more

See all Meetings/workshops